Don’t Lose Focus on Vision Health During COVID: Glaucoma Expert Shares His Tips for Healthy Eyes

New York, NY, September 22, 2020 — The COVID-19 pandemic may have changed the way we visit our doctors, but it shouldn’t prevent us from staying up-to-date with our usual health care appointments, including vision checkups. 

“During the coronavirus pandemic, people should guard their eyes with glasses or face shields to protect their eyes from virus infection," says Dr. Daniel Laroche, Director of Glaucoma Services and President of Advanced Eyecare of New York. People also need to know, even though there are many concerns about COVID-19, common-sense precautions can significantly reduce the risk of infection, he says, adding: “Wash hands frequently, follow good contact lens hygiene and avoid rubbing or touching our mouth, nose and especially our eyes.'' Dr. Laroche is also affiliated with the New York Eye and Ear Infirmary of Mount Sinai, Island Eye Surgical Center and New York University.

The COVID-19 pandemic has also changed the way people visit their doctors. For patients over 60, Dr. Laroche advises it's better to stay home and do telehealth over the phone or video consultation until the pandemic flattens. He also encourages people to wear face masks on visits and maintain social distancing, even if they are in a health clinic.
 

“Eyesight or human vision is one of the most important senses. As much as 80 percent of what we feel comes through our sense of sight. By protecting the eyes, people will reduce the chance of blindness and vision loss while also staying on top of any developing eye diseases, such as glaucoma and cataracts. A healthy brain function requires a healthy vision. The brain is our most essential organ, and it allows us to control other organs. Normal and healthy vision contributes to improved learning and comprehension for a better quality of life,” says Dr. Laroche.

Dr. Laroche says there is another critical issue that COVID-19 has brought to the forefront and that is the issue of health care disparities among Black and Brown people. “Nationally, African American deaths from COVID-19 are nearly two times greater than would be expected based on their share of the population. In four states, the rate is three or more times greater. In 42 states, plus Washington, D.C., Hispanics make up a greater share of confirmed cases than their share of the population. In eight states it’s more than four times greater,” he says, adding: “In stark contrast, white deaths from COVID-19 are lower than their share of the population in 37 states.”

Dr. Laroche says there are several things that can be done to not only address but to help combat this issue:

1.  Increase the number of Black and Afro-Latino physicians worldwide.

2.  Implement universal health care.

3.  Increase wealth and education which produces better health.

4.  Provide a living income stipend for poor people to access food and reduce malnutrition.

5.  Eliminate racism to reduce stress.

6.  Identify white supremist organizations as terrorist groups.

7.  Recommend all corporations have people of color in the top management and leadership positions.

8.  Eliminate sole reliance on standardized testing as the criteria to be used at entry to magnet schools. 

9.  Provide more funding to reduce homelessness and for mental health.

10. The government should also require medical school, research and hospital funding to diversify and benefit people of color.

About Dr. Daniel Laroche
 

Dr. Laroche is an exceptional glaucoma specialist in New York. He studied and received his bachelor's degree from New York University and a medical doctorate with honors in research from Weil Cornell University Medical College. He underwent a medical internship at Montefiore Hospital and finished his ophthalmology residency at Howard University Hospital in Washington D.C., where he was the chief resident in his third year. He later completed his glaucoma fellowship at New York Eye and Ear. 

For more information about Dr. Laroche, please call 212-663-0473 or visit: www.advancedeyecareny.com.

###

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

  • Signed agreements relate to vaccine candidate using Sanofi's recombinant protein-based technology combined with GSK's pandemic adjuvant 
  • Both companies are committed to making their COVID-19 vaccine affordable and available globally 

TORONTO, Sept. 22, 2020 /CNW/ - Today, Sanofi and GSK announce the signing of agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021.  

"This announcement showcases our unwavering commitment to develop a COVID-19 vaccine that is available to everyone when it comes to market," said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur. "To address a global health crisis of this magnitude, it takes partnerships and we are grateful to Canada for its collaboration, and to GSK for partnering with us to develop a safe and effective vaccine." 

Roger Connor, President of GSK Vaccines added, "GSK is proud to be working in partnership with Sanofi to make this vaccine available as soon as possible in Canada. Both companies have significant R&D and manufacturing capability worldwide and are already working hard to scale up production. This announcement from the Government of Canada supports our ongoing efforts."

Both companies' global manufacturing networks will play a pivotal role in the production of the COVID-19 vaccine for Canada. Additionally, Research and Development at Sanofi's Toronto vaccine manufacturing site will play a role in process and analytical development along with clinical manufacturing to support Sanofi Pasteur's overall global efforts to develop and manufacture a vaccine that protects against COVID-19.

"Sanofi has a long-standing legacy of developing safe and effective vaccines for Canadians," remarks Jean-Pierre Baylet, General Manager, Sanofi Pasteur Canada. "The partnership with the Government of Canada marks a key milestone in protecting and serving the Canadian population against COVID-19 and builds on our Toronto manufacturing site's more than 100-year history as a reliable public health partner."

Sanofi is leading the clinical development and registration of the COVID-19 vaccine, and a Phase 1/ 2 study was initiated on September 3 with a total of 440 subjects being enrolled. The companies anticipate results in early December 2020 to support the initiation of a pivotal Phase 3 study before the end of the year. If the data is sufficient for regulatory application, it is planned to request regulatory approval in the first half of 2021. In parallel, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant respectively with the target of producing up to one billion doses in total per year, globally.  

On the front lines in the fight against COVID-19

Sanofi is also developing a messenger RNA vaccine candidate in partnership with Translate Bio. This is in addition to continuing to develop, manufacture and supply a broad portfolio of life-saving vaccines and to ensure that patients have continued access to our medicines. More information about Sanofi's response to COVID-19 can be found here.

About GSK 

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally. For further information, please visit www.gsk.com

About Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life

SOURCE Sanofi Canada

Experience the Freedom of Radical Self-Acceptance with Transformative Healing Method

Boston, MA, September 22, 2020 — Do you constantly wonder what you’re saying, doing or thinking that’s causing you to feel “less than”? Are you always looking for ways to fix something about yourself? You’re not alone—far from it, in fact—and the good news is that you have the power to find your way back to the person you know you are deep down. It’s been inside you all along. 

There Is Nothing to Fix: Becoming Whole through Radical Self-Acceptance from Suzanne Jones may be the last self-help book you will ever need. Jones has helped thousands of participants with her life-changing somatic healing program, and in her book she leads you on a journey back to your authentic self by guiding you through a personal exploration of recovery, growth and resilience. There Is Nothing to Fix is The Power of Now meets Brené Brown meets the #MeToo movement. Interspersed with case studies and stories of real people—stories you can connect with—the book illustrates the power of Jones’s approach to create innate healing and hope.

Jones begins where most teachings on self-compassion, emotional regulation and healthy relationships end, by going to the source of lasting change—the body. This book provides a practical lens through which readers can understand their responses and emotions while offering step-by-step guidance for changing these responses, all with an emphasis on compassion and empowerment. Through this revolutionary approach you will be able to experience true freedom from the constant urge to fixyourself from the outside. Jones teaches you everyday tools to build self-confidence, self-compassion and most important, self-acceptance—tools that have been within you all along.

In today’s struggle to feel connection and approval in our chaotic and critical world, There Is Nothing to Fix teaches us how to suspend judgment, become curious and find emotional freedom from within.

Suzanne Jones is an expert in the field of trauma recovery through somatic methods. She has presented workshops and talks at Omega Institute, Kripalu, mental and behavioral health facilities in the greater Boston area, and national conferences. She has been profiled on CNN and in Yoga Journal, the New York TimesShape and Whole Living, and she's been interviewed by author Rick Hanson for his Foundations of Well-Being online course. Jones founded the TIMBo Collective (formerly called yogaHOPE) in 2006 and developed the TIMBo program for transforming trauma in 2009. Since its launch, her program has been delivered to over 4,000 women in the U.S., Haiti, Kenya and Iran, and helped transform client care at organizations in Massachusetts; Washington, DC; and Georgia, serving women overcoming homelessness, addiction and domestic violence. Jones also writes a blog for the TIMBo Collective and Elephant Journal

There Is Nothing to Fix is her first book and has won a silver medal from the Nonfiction Author’s Association book awards, a bronze medal from the Wishing Shelf Book Awards, was a finalist in the International Book Awards and has been nominated for a 2020 Readers’ Choice award. 

For more information, please visit www.suejonesempowerment.com, or connect with the author on Instagram: @thereisnothingtofix; or on Facebook: There is Nothing to Fix.

There Is Nothing to Fix: Becoming Whole through Radical Self-Acceptance

Publisher: LAKE Publications 

ISBN-10: 1734083506 

ISBN-13: 978-1734083507

Available from Amazon.comAudible.comBarnesandNoble.com and Target.com

###

DECN ANNOUNCES COMPLETION OF CRITICAL INSTRUCTIONAL VIDEOS FOR ITS GENVIRO! SALIVA SWIFT KIT FOR USA AND INTERNATIONAL PROFESSIONAL USE 

visuals will accompany distribution of company’s GenViro! Swift Kits globally and also be posted on the web site in english, and with sub-titles in german, russian, spanish and french

LOS ANGELES, CA—September 22, 2020 / Decision Diagnostics Corp. (OTC: DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has completed the two professional use instructional videos that will accompany the Genviro! Covid-19 Saliva Swift Kit to market both in the US and internationally. The videos provide step-by-step instructions for professionals to follow to obtain the most accurate results with each and every use of the product. As stated in a prior press release, the international product launch for GenViro! Swift will commence on September 26, 2020, and is expected to be rolled out over several weeks with pricing having been recently announced.

“Achieving accurate results using the Genviro! Swift Kits among professionals and eventually with at-home users will rely heavily on the ability to properly administer the test. That’s why we spent significant time and effort on the production and final video product to create what we believe are straightforward and easy to follow instructions.  Instructional videos are a part of both the FDA EUA and CE Mark Iso emergency processes.  There will actually be 6 total videos.  Two in English, one each for the domestic and international product versions, and then with sub-titles added, one each in German, Russian, Spanish and French,” said CEO Keith Berman. 

As stated in a prior announcement, the Genviro! Covid-19 Saliva Swift Kits had already completed a rigorous round of testing at the company’s manufacturing and product development facility in Daegu, Korea. 

ABOUT DECISION DIAGNOSTICS CORP

Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With newly inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market. The company's new GenViro!™ product designed to test for Covid-19, is not yet available in the United States or Puerto Rico, but Emergency (EUA) Waivers are in process with the U.S. FDA.  On September 26, 2020 the company plans to launch its International package versions of its GenViro! Swift Kit and Swift Meter.

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of September 21, 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.

info@decisiondiagnostics.co

sdoniger@bdcginc.com

Twitter: @covidswiftkit
www.genultimate.com
www.genultimatetbg.com

www.pharmatechdirect.com

Adventure-Filled Story Woven with Faith and Family Values

Shreveport, LA, September 22, 2020 — Matt Loman has already saved his family and his village from famine, finding his life’s true purpose in the process. But the journey toward his ultimate destiny is far from over, and just two days into his much-anticipated honeymoon, a compelling voice in his dreams pleads with him to “come home.”  

Following the voice, Matt embarks on an adventure that few could imagine, as he spars with a band of crazed warriors, gets stuck in an enormous web and is nearly torn to shreds by giant beasts. How will he explain his latest escapades to his beautiful young wife, Patience?  

With the Kingdom of Truevine and all that is good threatened by evil forces, it’s up to Matt and Patience to push beyond their own strengths, draw upon their faith and find the answer to saving the kingdom and their lives. Will they find it in time?

Coming Home takes readers on a family-friendly journey filled with faith, suspense and sweet romance. Written by father-daughter authors Bruce and Vernae Ewing, Coming Home unfolds one adventure at a time, with colorful characters and clever challenges for Matt and Patience that subtly reinforce family values and inspire readers to seek out their own true purposes. Suitable for all ages, Coming Home is an immensely enjoyable read that makes the perfect choice for family story time.

Dr. Bruce Ewing has been a pastor for 48 years, with 28 of those spent as a military chaplain. He has been married to the love of his life, Valerie, for 47 years and is the father of two precious daughters, Brecia and Vernae. Dr. Bruce is a Marriage and Family Relationship Consultant, teacher of biblical principles and teller of stories. His love for God and family is the catalyst for his writing. Love healed his own heart, so he tells stories to inspire others to discover the same grace he has received. 

Co-author and Dr. Bruce’s daughter Vernae Ewing Thompson holds a BS in marketing and an MBA. She is married to singer/songwriter Lance Thompson. Vernae is an actor, model, producer, director and business owner. She acquired her love for books and writing through her childhood experiences while listening to her father’s wild bedtime adventure stories and stories from the Bible.  

Coming Home is the second installment in the popular Treasure Tree series. Watch for the next book, The Reign of War. For more information, please visit www.thetreasuretreebook.com, or connect with the authors on Instagram: @thetreasuretreebook; or on Facebook: thetreasuretreebook.

Coming Home (Book 2 of the Treasure Tree series)

Publisher: High Bridge Books

ISBN: (Paperback): 978-1-946615-65-7

Available from Amazon.com

###

Top Benefits of Fitness Training With Professionals 

Working out is important and has many benefits. However, you may not be able to get the results that you want if you work out by yourself. That is why it is a good idea to train with a professional. There are several reasons that you will need to work out with a professional.

Education

Fitness trainers are knowledgeable and educated. They know how you can get the most out of your workout. They can also help you avoid injuries. Additionally, they can use their education and training to put together the right fitness routine for your specific body type and goals. While you can google generic workouts online, you won’t be able to get the personalized experience without working with a real living expert in the field.

Motivation

Exercising can be a hassle at times. You need someone who can motivate you. Your professional fitness trainer will encourage you and give you the motivation that you need in order to stay on the right track. Again, this can be personalized to your personality. Some people benefit more from tough love, while others need someone to give them permission to take a break day. Having someone on hand who can assess your needs quickly and give the support you need will help you keep on schedule.

Personalized Plan

There is no one-size-fits all when it comes to fitness training. For some, a fitness program they found online with no feedback can be just fine, while others have health concerns that need adjusting for. Without a professional, you won’t know which parts of an exercise routine are necessary, which are harmful for your personal conditions, and which are meant for people in a completely different fitness category than you.

Variety

Boredom is one of the reasons that many people do not stick to a workout routine. Your fitness trainer will develop a routine for you that has a variety of exercises. The routine will include cardio, weights and body weight exercises. The changes will keep the exercise routine fun and exciting, as opposed to following the same tired routine you found on a flier. Instead of changing exercise plans every few weeks, stick with the same professional who can help shake up your routine for you.

Challenging

One of the reasons that people do not get the results that they want is because they are not challenged enough. Many people also tend to get bored while they are working out because they are not challenged enough. Your trainer will make sure that you are challenged enough while you are working out. They will challenge you by pushing you past your comfort zone. They will challenge you to do more than you ever could imagine. It can be rewarding to push yourself past your comfort zone.

If you want to get more out of your training regimen, then it is a good idea for you to hire a professional trainer. They will give you the motivation that you need. They will also educate you and develop a personalized plan that has a variety of exercises. Furthermore, they will challenge you and push yourself past your comfort zone.

4 Exercises That Can Increase Your Balance and Lower Leg Strength

If you’ve been experiencing balance issues, it may be a sign that you have weak lower leg muscles. You can enhance the strength of these muscles by following a well laid out workout plan. Here are four exercises that are aimed at building up lower leg strength and increasing a person’s balance.

Single Leg Stance

It’s best to start things off with an easy balance exercise. You’ll want to have a solid chair or a table that you can hold onto for support when necessary. Lift one leg off of the ground and balance your weight on your remaining foot. Hold the position for 30 seconds to start with. Proceed to switch sides and repeat the stance. Do 3 sets of 10 reps for each leg.

The Line Walk

Most people are familiar with the line walk that police ask those they suspect are drunk to perform. This is actually a great exercise to enhance balance and build up leg strength. For those who are unfamiliar with this walk, we’ll explain. You want to put your right foot directly in front of the toes on your left foot. Then, move your left foot directly in front of the toes of your right foot. Continue this line walk for 3 sets of 20 steps.

Rock the Boat

Rock the boat is somewhat similar to the single leg stance. You’ll want to stand behind a solid chair or table. Have your feet positioned about width hip apart. Slowly lift your left leg to your side. Put all of your weight on your right foot. Hold this weight for 5 seconds. Slowly return your left foot to the floor and lift your right foot out to your side. Hold your right foot for five seconds, and return it to the ground. Do five to seven sets per side.

Back Leg Raise

This exercise is best performed from the prone position. However, you can do it standing while grasping the back of a solid chair for support if necessary. You start by slowly extending your right leg straight back. You don’t want to bend at the knee or point your toes. Simply raise your right leg in the air behind you for one to five seconds. Next, switch to your left leg and repeat. You’ll want to perform 10 to 15 reps per side.

Once you get skilled at these exercises, you can move on to leg strengthening that requires the use of strength training equipment. This can really help you keep up your trajectory and maintain both balance and strength.

Strengthening your lower legs and enhancing your balance can be done with the same exercises. The above are four very basic exercises that can help to get you started on your strength journey. It’s best to start with these basics and work on increasing the number of sets that you can complete each day.

Brooke Chaplan is a freelance writer and blogger. She lives and works out of her home in Los Lunas, New Mexico. She recommends looking into unflavored CBD animal tinctures for your pet. For more information, contact Brooke via Facebook at facebook.com/brooke.chaplan or Twitter @BrookeChaplan

Working From Home Can Be a Pain in The Neck and Back, Get Back-Popping, Knot-Kneading Relief With The Chirp Wheel

www.gochirp.com

Image

Due to the COVID pandemic, more people across the United States are working from home than ever before, approximately 25-30% of the workforce. While there are some bonuses like no commuting in traffic and working in your sweatpants, a major downside has developed: new or worsening neck and back pain. The most logical culprit is makeshift home offices that are not ergonomically correct. Not everyone has the luxury of a designated home office.  In the U.S., back pain is a leading cause of missed days at work and school. Without proper care, approximately 20% of people with acute lower-back pain will have persistent symptoms within a year.  To add insult to injury, many are afraid to seek outside care for fear of exposing themselves to people during the pandemic.  

PRODUCT DETAILS

  • Get back-popping, knot-kneading relief
  • Effortlessly release low back tension
  • Roll out headaches and neck pain
  • Sleep better by relaxing tight muscles

 PRODUCT DESCRIPTION

The Chirp Wheel is designed to fit perfectly between your shoulder blades, targeting the muscles that go up and down your spine. As your back is strained from the countless activities you do, those muscles lock up, and cause even more pain. The Chirp Wheel massages those muscles, relaxing your back and relieving all of the pain.

What age range is Chirp Appropriate For?  Chirp’s customers range from 18-80. The Wheels can even hold up to 500 lbs, so it's built 100% PVC free and won't break.  If your back pain is the result of a serious accident or injury, please consult a doctor first. 

How often should one use the Chirp Wheel +

It is recommended that the Chirp Wheel+ is used for 5-10 minutes a day, or as needed. The Chirp Wheel+ is designed to reduce tension, target knots, and help 'open' your vertebrae. Be patient. Your body may need some time to decompress the spine and relax all those tight muscles."

See the Chirp Wheel + In Action – Click link to view 

Chirp Wheels are Available in a range of Sizes 

12" Gentle :$65.00

10" Medium: $55.00

6" Deep Tissue: $45.00

3 Wheel Pack for $99.00 

The 3 Problems with Other Back Pain Relief Solutions:

1. They are expensive. Chiropractors are a good option, but feeling like you have to see one every week costs far more in time and money than the Chirp Wheel. In fact, the company has a network of over 3,000 Chiropractors and Physical Therapists that recommend the wheel, especially in-between visits.

2. They don't fit where you need them to. Foam rollers can't put the pressure in the right places to really relieve the pain. The Chirp Wheel has a Patent Pending Spinal Canal™ and Compression Sensitive™ padding to ensure comfort and relief.

3. They don't store well. Inversion tables take up half the living room, and it's impossible to fit a foam roller in your bag when you are on the go. The Chirp Wheel is lightweight and travels easy!

A Difference You Can Feel 

 Relaxing 4-way stretch with their patented Spinal Canal™

  • Deep tissue massage with our ergonomic design
  • Lasting relief with only 5 minutes of rolling out
  • Sleep better by relaxing tension in your neck, upper back, and lower back

About The Company

Tate Stock CEO invented the Chirp Wheel+, a back-pain relief wheel. He started Chirp by making yoga wheels in a barn with $400 of sewer pipe, and $50 of yoga mat. He then listed these wheels on Amazon and sold $12k worth in the first two weeks. Tate focused on selling to the yoga market for the first year and a half, and achieved 180K in sales, but saw demand for a similar product that could relieve back pain. This led to the development of the Chirp Wheel+. The Chirp Wheel+ is made out of 100% PVC free injection molding that can hold over 500lbs and is wrapped in compression sensitive padding. The Chirp Wheel+ features a patent-pending spinal canal to relieve pressure along the spine, and is available in three sizes. Tate Stock bootstrapped Plexus Yoga, renamed Chirp, into a startup that projects $40 million in sales this year. Approximately 1 million people have used these wheels for drug-free relief. The Chirp Wheel+ is the only FDA registered Class 1 Medical device of its kind. Unlike foam rollers, the Chirp Wheel fits perfectly between your shoulders and cradles to the spine. It’s 5-inch width, and spinal canal is designed to give Chirp’s signature, four-way stretch. Over 60% of Chirp’s team members are women. Chirp works with over 3,000 physical therapists and chiropractors that use and recommend our product daily, including leading spinal specialists from prestigious Yale University. The Chirp Wheel+ is the highest funded pain relief product in crowdfunding history.

About the Founder: Tate Stock

Image

 Tate Stock founded Chirp in 2015 at the age of 23. He grew up on a farm in Pasco, Washington. Prior to developing the Chirp Wheel+, he was an undergraduate student at Brigham Young University in Provo, Utah, and received his degree in economics. Forbes featured him on its prestigious 30 under 30 list, for manufacturing in 2020. In addition to being a young entrepreneur, family is paramount to Tate. He is married with two young sons. As a hobby, Tate is a registered boat captain.

COVID-19 Contributes to Uptick in Opioid-Related Deaths

Baltimore, MD, September 21, 2020 — Social isolation and reduced access to healthcare during the lockdown, among other factors, have led to a rise in opioid-related deaths, experts say. And according to their estimates, it’s only going to get worse. Similarly, Authorities across Texas, Pennsylvania, Florida and New York are also reporting rises in overdoses during the COVID-19 crisis.

On the frontlines working to curb the impact of the opioid crisis is Dr. Paul Christo, anAssociate Professor in the Division of Pain Medicine at the Johns Hopkins University School of Medicine.

"The number of fatalities from opioid-related overdoses could be nearly 30 percent higher than reported due to missing information or incomplete death records,” he says. “The worst fear is that because of social isolation, and people are not being found or treated immediately."

The opioid epidemic today progressed in three phases, according to the Centers for Disease Control and Prevention. The first involves deaths caused by prescription opioids, the second, an increase in heroin use, and the third, a surge in the use of synthetic opioids or fentanyl. Experts say the U.S. is right in the middle of the third phase of the epidemic, due to the increasing availability of fentanyl and increasing rates of overdose deaths involving synthetic opioids.

According to a recent study there were 632,331 drug overdoses between 1999 and 2016. Most of these deaths (78.2 percent) were drug overdoses with known drug classification. Moreover, 21.8 percent were unclassified drug overdoses. A further investigation revealed that for unclassified drug overdoses, 71.8 percent involved opioids, translating to 99,160 additional opioid-related deaths.

There were over 70,000 drug overdose deaths in 2017, according to an estimate from the CDC. Based on findings from the new study, over half of those deaths — about 47,000 — are suspected of having involved opioids.

Another study on opioid overdoses found that the number of drug overdose deaths decreased by 4 percent from 2017 to 2018. In 2018, more than 67,000 people died from drug overdoses, making it a leading cause of injury-related death in the United States. Almost 70 percent involved a prescription or illicit opioid of those deaths.

“COVID 19 impacted the drug supply chain by closing borders on some regions, and it led to the higher death rate,” Dr. Christo explained. He added that drugs become more challenging to get, and the potency of overdose goes up. It also impacts the price, everything goes up, and in that sense, it becomes more deadly each day, according to Dr. Christo.

About Dr. Paul Christo 
 

Dr. Paul Christo serves as Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital. He is the author of Aches and Gains, A Comprehensive Guide to Overcoming Your Pain. Dr. Paul Christo also hosts an award-winning, nationally syndicated SIRIUS XM radio talk show on overcoming pain called, Aches and Gains®. For more information about Dr. Paul Christo. Please visit www.paulchristomd.com.

Mitsubishi Tanabe Pharma Canada Announces Treatment for Amyotrophic Lateral Sclerosis (ALS) now Eligible for Coverage through Veterans Affairs Canada and Indigenous Services Canada

TORONTO, Sept. 21, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now reimbursed by Veterans Affairs Canada (VAC) and Indigenous Services Canada via the Non-Insured Health Benefits (NIHB) Program. 

"We would like to thank Veterans Affairs Canada and Indigenous Services Canada for providing eligible ALS patients access to this treatment," said Atsushi Fujimoto, President, MTP-CA. "Including RADICAVA on these formularies is an important step to support those living with ALS who are eligible under the federal programs." 

In addition to VAC and NIHB, RADICAVA is also listed on the:

  • Régie de l'assurance maladie du Québec (RAMQ) formulary (special authorization) 
  • Ontario Drug Benefit Formulary (Exceptional Access Program) 
  • Alberta Drug Benefit List (special authorization) 
  • New Brunswick Drug Plan (NBDP) formulary (special authorization) 
  • Manitoba Drug Benefits and Interchangeability Formulary (special authorization) 
  • Saskatchewan Formulary (special authorization) 
  • Nova Scotia Drug Formulary (special authorization) 
  • British Columbia (BC) PharmaCare Formulary (special authorization)

MTP-CA continues to have discussions with other provinces regarding the listing of RADICAVA under additional publicly funded drug programs.

About RADICAVA® (edaravone) 
RADICAVA (edaravone) is indicated to slow the loss of function in patients with amyotrophic lateral sclerosis (ALS), as measured by the ALS Functional Rating Scale - Revised (ALSFRSR).Edaravone was discovered and developed for ALS by Mitsubishi Tanabe Pharma Corporation (MTPC) through an iterative clinical development platform over a 13-year period. In 2015, edaravone was approved for use as a treatment for ALS in Japan and South Korea. RADICAVA was approved by the U.S. Food and Drug Administration in May of 2017. Marketing authorization was granted in Canada in October 2018 and Switzerland in January 2019.

About Mitsubishi Tanabe Pharma Canada, Inc.
Based in Toronto, Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) with a goal to provide therapies for some of the most difficult-to-treat diseases, including ALS. For more information, please visit www.mt-pharma-ca.com.

About Mitsubishi Tanabe Pharma America, Inc.
Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America. It was established by MTPC to commercialize approved pharmaceutical products in North America with plans to expand its product line through collaborations with partners. For more information, please visit www.mt-pharma-america.com.

__________________________________
1 RADICAVA® (edaravone) Canada Product Monograph. October 2019https://www.mt-pharma-ca.com/our-product/

SOURCE Mitsubishi Tanabe Pharma Canada, Inc.